Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02233946 · ClinicalTrials.gov registry record · NA
Computerized Alcohol Screening for Children and Adolescents (cASCA) in Primary Care
A NA study of Prevention Harmful Effects, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 871
- Enrollment target
- 5
- Study locations
NCT02233946: Completed NA study of Prevention Harmful Effects, sponsored by Boston Children's Hospital.
NCT02233946 is a NA study of Prevention Harmful Effects that has completed, run by Boston Children's Hospital. The registered enrollment target is 871 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (38% lower). The trial reports 5 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02233946, a NA study of Prevention Harmful Effects, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 871 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to assess the psychometric properties of a brief screening questionnaire for alcohol problems among 9- to 18-year-old patients in pediatricians' offices, and to pilot test a personalized, computer-facilitated brief intervention delivered on a tablet computer and by the provider based on screening results.
Primary Outcome
Median (and interquartile range) for times to first use for the cSBI and Treatment As Usual (TAU) groups
Conditions Studied
Interventions
- BEHAVIORAL computer-facilitated brief intervention
Study Locations (5)
Massachusetts
- Tufts Medical Center - Boston
- Boston Childrens Primary Care Center - Boston
- Longwood Pediatrics - Boston
- East Boston Neighborhood Health Center - East Boston
- Lexington Pediatrics - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 871 participants |
| Start Date | 2015-01 |
| Est. Completion | 2018-05-31 |
| Phase | NA |
What the finished NCT02233946 record still lists
NCT02233946 is an interventional study that assigns participants to a tested intervention. The registered 871 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (38% lower).
The record links to 1 condition, with Prevention Harmful Effects appearing as the primary indexed condition, and to 1 intervention - of which computer-facilitated brief intervention is the first listed.
NCT02233946 lists 5 locations in 1 state (Massachusetts).
Frequently Asked Questions
What is clinical trial NCT02233946 about?
NCT02233946 is a clinical study titled "Computerized Alcohol Screening for Children and Adolescents (cASCA) in Primary Care". The purpose of this study is to assess the psychometric properties of a brief screening questionnaire for alcohol problems among 9- to 18-year-old patients in pediatricians' offices, and to pilot test a personalized, computer-facilitated brief intervention delivered on a tablet computer and by the p...
What is the current status of trial NCT02233946?
This trial is currently completed. It is a NA study. The enrollment target is 871 participants. The study started on 2015-01. Estimated completion is 2018-05-31.
What conditions does trial NCT02233946 study?
This clinical trial studies the following conditions: Prevention Harmful Effects.
What interventions are being tested in trial NCT02233946?
The interventions under investigation include: computer-facilitated brief intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02233946?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02233946 being conducted?
This trial has 5 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02233946's enrollment target sits among peer trials
871 130th of 2000 higher than 1,871 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04097145 · 870 participants · NA
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
- NCT06822790 · 869 participants · Phase 3
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
- NCT06077760 · 868 participants · Phase 3
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
- NCT04933552 · 867 participants
Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia